Global protein market report highlights whey crisis and GLP-1 demand

5 min read     Updated on 08 Jun 2026, 08:44 PM
scanx
Reviewed by
Radhika SScanX News Team
AI Summary

Market Decipher's Global Protein Market Report, 2026–2036, values the industry at $133 billion, driven by a whey supply crisis, GLP-1 pharmaceutical demand, and FMCG expansion. Protein supplements and ingredients are seeing double-digit growth, while emerging technologies like precision fermentation are accelerating. The report emphasizes the urgency of strategic positioning amid supply constraints and evolving consumer needs.

powered bylight_fuzz_icon
42477280

*this image is generated using AI for illustrative purposes only.

Market Decipher has released the Global Protein Market Report, 2026–2036, detailing a global protein industry valued at $133 billion that is undergoing a structural reset. The report identifies three converging forces reshaping the market: a pharmaceutical revolution driven by GLP-1 medications, a once-in-a-generation whey supply crisis with spot prices at USD 11/lb, and a fundamental shift in consumer expectations for protein functionality. These disruptions are creating a volatile environment where the headline 8.4% CAGR understates the immediate volatility in pricing and supply chains.

Market Segmentation and Growth

The report breaks down the market into four primary segments: Protein Supplements, High-Protein FMCG, Protein Ingredients, and Emerging Proteins. Protein Supplements are valued at USD 33.5 Bn with a ~13.2% CAGR, while High-Protein FMCG represents the largest segment at USD 70.2 Bn with an ~8.1% CAGR. Protein Ingredients are valued at USD 30.1 Bn with an ~11.6% CAGR. Emerging Proteins, including precision fermentation and insect protein, are projected to grow at a 17% CAGR from a smaller base of USD 15.2 Bn.

Protein Supplements Market Breakdown

Segment 2026 $ million 2036 $ million CAGR
Pure Whey WPC 8,634 37,438 15.8 %
Pure Whey WPI 4,568 16,641 13.8 %
Whey WPC/WPI Blend 3,369 9,739 11.2 %
Plant Protein Powders 6,222 20,751 12.8 %
Women Protein Products 2,144 7,406 13.2 %
Protein Blends (Multi-source) 5,624 16,702 11.5 %
Hydrolysed Whey Supplements 2,965 7,349 9.5 %
SECTION TOTAL 33,526 1,16,025 13.2 %

Whey Supply Crisis and Capacity Constraints

The report highlights a critical whey supply crisis driven by a structural demand shock and insufficient processing infrastructure. WPC80 costs have surged 108% over two years, while WPI is up 139%. US WPC and WPI volumes are largely forward-contracted into 2026, forcing global buyers to shift sourcing to Europe and regional alternatives. The global dairy industry has announced approximately USD 11 billion in investments, but significant supply relief is not expected until Q3 2027 or later. Major capacity additions include Glanbia adding 10 million pounds of WPI capacity and Tirlán committing €126 million to premium whey expansion.

High-Protein FMCG Expansion

High-protein products are moving beyond specialist stores into mainstream grocery aisles, appearing in items such as Pop-Tarts, Kraft Mac & Cheese, and Doritos. This transformation is driving the High-Protein FMCG segment, which includes categories like RTD protein drinks, protein bars, and high-protein yogurt. The segment is projected to grow from USD 70.2 Bn to USD 153.6 Bn by 2036. Key growth areas include clear/juice-style RTD protein beverages and GLP-1-specific nutritional products, such as Danone's Oikos protein shake launched in May 2025.

High Protein FMCG Market Breakdown

Segment 2026 $ million 2036 $ million CAGR
High Protein Milk 5,689 12,511 8.2 %
High Protein Yogurt 12,500 24,820 7.1 %
HP Meat Snacks 2,906 6,570 8.5 %
High Protein Chips 898 1,868 7.6 %
HP Flours 2,532 5,466 8.0 %
Baking Mixes 2,268 5,223 8.7 %
HP Cheese 4,513 8,713 6.8 %
High Protein Fish 8,527 16,006 6.5 %
High Protein Chicken 1,121 2,085 6.4 %
High Protein Eggs 4,582 8,682 6.6 %
RTD Protein Drinks 984 3,029 11.9 %
RTD Protein Shakes 2,604 8,684 12.8 %
Protein Bars 12,122 30,874 9.8 %
HP Breakfast Cereals & Oats 6,413 13,718 7.9 %
HP Pasta & Noodles 964 1,932 7.2 %
Others 1,594 3,410 7.9 %
SECTION TOTAL 70,217 1,53,593 8.1 %

Protein Ingredients and Emerging Technologies

The Protein Ingredients market is projected to grow from USD 30.1 Bn to USD 93 Bn by 2036. The report identifies Pea Protein Isolate (12.5% CAGR), Collagen Peptides (11.4% CAGR), and WPI Bulk (14.0% CAGR) as high-conviction investment theses. Emerging technologies, particularly precision fermentation, are moving from speculation to commercial reality, with the segment projected to reach USD 22,387 million by 2036 at a 48% CAGR. Regulatory approvals from bodies like the FDA, EFSA, and FSSAI remain critical gating factors for these emerging segments.

Protein Ingredients Market Breakdown

Segment 2026 $ million 2036 $ million CAGR
Whey Protein WPC Bulk 6,621 29,209 16.0 %
Whey Protein WPI Bulk 4,616 17,113 14.0 %
Hydrolysed Whey Protein 1,902 5,401 11.0 %
Casein & Caseinates 3,602 7,777 8.0 %
Milk Protein Concentrate (MPC) 2,832 6,229 8.2 %
Soy Protein Isolate 3,446 8,462 9.4 %
Pea Protein Isolate 1,524 4,949 12.5 %
Wheat Protein 1,728 2,869 5.2 %
Rice Protein 983 1,845 6.5 %
Egg Protein 1,122 2,291 7.4 %
Collagen Peptides 883 2,599 11.4 %
Multi-Protein Blends 1,800 4,261 9.0 %
SECTION TOTAL 31,060 93,006 11.6 %

GLP-1 and Strategic Outlook

The adoption of GLP-1 medications is tightening whey demand as protein is prescribed to preserve lean mass. The GLP-1 diet protein market is valued at USD 3.1 Bn in 2026 and is projected to reach USD 15.4 Bn by 2036, growing at a 17.4% CAGR. The report warns that companies waiting for the supply crisis to resolve risk losing competitive advantage, as early commitments to capacity from processors like Glanbia, Tirlán, and Fonterra are pre-allocating available WPI output.

Historical Stock Returns for Ambar Protein Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-2.71%+0.57%-5.50%-33.76%-29.12%+2,295.92%

How will the sustained high cost of whey protein accelerate the consumer shift toward plant-based and precision fermentation alternatives before 2027?

What specific regulatory milestones are required for precision fermentation to scale from niche speculation to mainstream cost-competitiveness by 2030?

To what extent will the integration of high-protein ingredients into mainstream FMCG goods like Pop-Tarts and pasta cannibalize sales from traditional supplement categories?

Ambar Protein Industries
View Company Insights
View All News
like17
dislike

Ambar Protein Industries reports FY26 net profit of ₹702.66 lakh

1 min read     Updated on 03 Jun 2026, 04:26 PM
scanx
Reviewed by
Ashish TScanX News Team
AI Summary

Ambar Protein Industries Limited reported a net profit of ₹702.66 lakh for FY26, with revenue from operations rising to ₹50,065.59 lakh. The Board approved the audited standalone financial results for the quarter and year ended March 31, 2026, and re-appointed Rajendra Natverlal Shah & Co. as internal auditor. The statutory auditor issued an unmodified opinion on the results.

powered bylight_fuzz_icon
41691144

*this image is generated using AI for illustrative purposes only.

Ambar Protein Industries Limited reported a net profit of ₹702.66 lakh for the financial year ended March 31, 2026, while revenue from operations increased to ₹50,065.59 lakh. The company's Board of Directors approved the audited standalone financial results for the quarter and year ended March 31, 2026, during a meeting held on May 30, 2026. The statutory auditor, M/s. Fenil P Shah and Associates, issued an audit report with an unmodified opinion on the standalone financial results.

For the quarter ended March 31, 2026, the company recorded a net profit of ₹246.41 lakh on revenue from operations of ₹14,679.97 lakh. Total income for the quarter stood at ₹14,701.83 lakh, while total expenses were ₹14,358.80 lakh. The basic and diluted earnings per share (EPS) for the quarter were reported at ₹4.29 each.

The full-year financial performance showed a total income of ₹50,143.72 lakh against total expenses of ₹49,205.13 lakh. The profit before tax for the year was ₹938.59 lakh, with a total tax expense of ₹235.93 lakh. Basic and diluted EPS for the year were ₹12.22. The company's only business segment is the manufacturing and selling of edible oil.

Financial Results for FY26

Particulars Year Ended 31.03.2026 (₹ in Lacs) Year Ended 31.03.2025 (₹ in Lacs)
Revenue from operations 50,065.59 42,162.30
Total Income 50,143.72 42,246.46
Total Expenses 49,205.13 40,943.36
Profit before tax 938.59 1,303.11
Net Profit 702.66 965.02
Basic EPS (₹) 12.22 16.78

Board Decisions

The Board approved the re-appointment of Rajendra Natverlal Shah & Co. as the internal auditor for FY 2026-27. Additionally, the Board approved related party transactions with Ankur Oil Industries regarding the sale of goods and job work, subject to shareholder approval. The company confirmed that the financial results were prepared in accordance with Indian Accounting Standards (Ind AS) and reviewed by the Audit Committee.

Pursuant to Regulation 47 of SEBI (Listing Obligations & Disclosure Requirements) Regulations, 2015, the company submitted newspaper clippings of the audited standalone financial results for the quarter and year ended March 31, 2026. The results were published in English and Gujarati newspapers on June 02, 2026.

Historical Stock Returns for Ambar Protein Industries

1 Day5 Days1 Month6 Months1 Year5 Years
-2.71%+0.57%-5.50%-33.76%-29.12%+2,295.92%

What strategies will Ambar Protein Industries implement to reverse the decline in net profit and EPS compared to the previous fiscal year?

How will the approved related party transactions with Ankur Oil Industries impact the company's operational margins in FY 2026-27?

What are the company's capital expenditure plans for the upcoming year to support the growth in revenue from operations?

Ambar Protein Industries
View Company Insights
View All News
like17
dislike

More News on Ambar Protein Industries

1 Year Returns:-29.12%